567 related articles for article (PubMed ID: 23278883)
21. Safety of parecoxib in patients with nonsteroidal anti-inflammatory drug-induced urticaria or angioedema.
Colanardi MC; Nettis E; Traetta P; Daprile C; Fitto C; Aloia AM; Di Leo E; Ferrannini A; Vacca A
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):82-5. PubMed ID: 18254487
[TBL] [Abstract][Full Text] [Related]
22. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z
J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
[TBL] [Abstract][Full Text] [Related]
23. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.
Sánchez-Borges M; Capriles-Hulett A; Caballero-Fonseca F
Am J Clin Dermatol; 2002; 3(9):599-607. PubMed ID: 12444802
[TBL] [Abstract][Full Text] [Related]
24. Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria.
Cavkaytar O; Arik Yilmaz E; Buyuktiryaki B; Sekerel BE; Sackesen C; Soyer OU
Allergy; 2015 Feb; 70(2):153-60. PubMed ID: 25353369
[TBL] [Abstract][Full Text] [Related]
25. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):154-8. PubMed ID: 16136765
[TBL] [Abstract][Full Text] [Related]
26. Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children.
Arikoglu T; Aslan G; Yildirim DD; Batmaz SB; Kuyucu S
Allergol Int; 2017 Jul; 66(3):418-424. PubMed ID: 27865769
[TBL] [Abstract][Full Text] [Related]
27. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of 76 patients with urticaria and angioedema induced by non-steroidal anti-inflammatory drugs (NSAIDs) in Japan].
Moriya M; Aihara M; Hirota R; Hirata Y; Ikinaga N; Takamura N; Kunimi Y; Uchida T; Ikezawa Z
Arerugi; 2011 Jun; 60(6):699-707. PubMed ID: 21709437
[TBL] [Abstract][Full Text] [Related]
29. Management of patients with nonaspirin-exacerbated respiratory disease aspirin hypersensitivity reactions.
Saff RR; Banerji A
Allergy Asthma Proc; 2015; 36(1):34-9. PubMed ID: 25562554
[TBL] [Abstract][Full Text] [Related]
30. [Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)].
Boehncke S; Boehncke WH
Dtsch Med Wochenschr; 2005 Oct; 130(40):2249-52. PubMed ID: 16208597
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis.
De Weck AL; Sanz ML; Gamboa PM; Aberer W; Blanca M; Correia S; Erdman S; Jermann JM; Kanny G; Kowalski M; Mayorga L; Medrala W; Merk A; Sturm GJ; Sainte-Laudy J; Schneider MS; Sczczeklik A; Weber JM; Wedi A
J Investig Allergol Clin Immunol; 2009; 19(5):355-69. PubMed ID: 19862935
[TBL] [Abstract][Full Text] [Related]
32. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*.
Kowalski ML; Makowska JS; Blanca M; Bavbek S; Bochenek G; Bousquet J; Bousquet P; Celik G; Demoly P; Gomes ER; Niżankowska-Mogilnicka E; Romano A; Sanchez-Borges M; Sanz M; Torres MJ; De Weck A; Szczeklik A; Brockow K
Allergy; 2011 Jul; 66(7):818-29. PubMed ID: 21631520
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response.
Doña I; Blanca-López N; Cornejo-García JA; Torres MJ; Laguna JJ; Fernández J; Rosado A; Rondón C; Campo P; Agúndez JA; Blanca M; Canto G
Clin Exp Allergy; 2011 Jan; 41(1):86-95. PubMed ID: 21155908
[TBL] [Abstract][Full Text] [Related]
34. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity.
Viola M; Rumi G; Valluzzi RL; Gaeta F; Caruso C; Romano A
Clin Exp Allergy; 2011 Jan; 41(1):96-103. PubMed ID: 21155909
[TBL] [Abstract][Full Text] [Related]
35. Acute phase inflammatory markers in patients with non-steroidal anti-inflammatory drugs (NSAIDs)-induced acute urticaria/angioedema and after aspirin challenge.
Kasperska-Zając A; Grzanka A; Czecior E; Misiolek M; Rogala B; Machura E
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1048-52. PubMed ID: 22348297
[TBL] [Abstract][Full Text] [Related]
36. Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs.
Asero R
Clin Exp Allergy; 2005 Jun; 35(6):713-6. PubMed ID: 15969659
[TBL] [Abstract][Full Text] [Related]
37. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
Wong JT; Nagy CS; Krinzman SJ; Maclean JA; Bloch KJ
J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
[TBL] [Abstract][Full Text] [Related]
38. Use of ketoprofen oral challenges to detect cross-reactors among patients with a history of aspirin-induced urticaria.
Asero R
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):187-9. PubMed ID: 16937749
[TBL] [Abstract][Full Text] [Related]
39. Patient-reported multiple drug reactions: clinical profile and results of challenge testing.
Ramam M; Bhat R; Jindal S; Kumar U; Sharma VK; Sagar R; Chadda RK
Indian J Dermatol Venereol Leprol; 2010; 76(4):382-6. PubMed ID: 20657119
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
